Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Bisaccia Lisa Create: Alert

All | News | Filings
Date FiledTypeDescription
05/05/2023 4 Bisaccia Lisa (Director) has filed a Form 4 on CHESAPEAKE UTILITIES CORP
Txns: Granted 765 shares @ $124.12, valued at $95k
02/13/2023 5 Form 5 - Annual statement of changes in beneficial ownership of securities:
05/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/22/2021 3 Bisaccia Lisa (Director) has filed a Form 3 on CHESAPEAKE UTILITIES CORP
04/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/13/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/07/2020 4 Bisaccia Lisa (EVP and Chief HR Officer) has filed a Form 4 on CVS HEALTH Corp
Txns: Paid exercise price by delivering 1,598 shares @ $55.72, valued at $89k
04/07/2020 4/A Bisaccia Lisa (EVP and Chief HR Officer) has filed a Form 4 on CVS HEALTH Corp
Txns: Granted 98,558 options @ $0
04/03/2020 4 Bisaccia Lisa (EVP and Chief HR Officer) has filed a Form 4 on CVS HEALTH Corp
Txns: Paid exercise price by delivering 1,109 shares @ $58.34, valued at $64.7k
Granted 98,558 options @ $58.61, valued at $5.8M
03/03/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/03/2019 4 Bisaccia Lisa (Director) has filed a Form 4 on Aramark
Txns: Granted 61 shares @ $0
06/03/2019 4 Bisaccia Lisa (Director) has filed a Form 4 on Aramark
Txns: Granted 71 shares @ $0
04/03/2019 4 Bisaccia Lisa (EVP and Chief HR Officer) has filed a Form 4 on CVS HEALTH Corp
Txns: Paid exercise price by delivering 2,411 shares @ $54.19, valued at $130.7k
Granted 141,405 options @ $54.19, valued at $7.7M
03/04/2019 4 Bisaccia Lisa (Director) has filed a Form 4 on Aramark
Txns: Granted 81 shares @ $0
03/01/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/01/2019 4 Bisaccia Lisa (Director) has filed a Form 4 on Aramark
Txns: Granted 4,908 shares @ $0
12/10/2018 4 Bisaccia Lisa (Director) has filed a Form 4 on Aramark
Txns: Granted 51 shares @ $0
10/03/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/04/2018 4 Bisaccia Lisa (Director) has filed a Form 4 on Aramark
Txns: Granted 45 shares @ $0
06/04/2018 4 Bisaccia Lisa (Director) has filed a Form 4 on Aramark
Txns: Granted 47 shares @ $0
04/03/2018 4 Bisaccia Lisa (EVP and Chief HR Officer) has filed a Form 4 on CVS HEALTH Corp
Txns: Paid exercise price by delivering 2,162 shares @ $62.21, valued at $134.5k
Granted 64,222 options @ $62.21, valued at $4M
03/05/2018 4 Bisaccia Lisa (Director) has filed a Form 4 on Aramark
Txns: Granted 44 shares @ $0
03/02/2018 4 Bisaccia Lisa (EVP and Chief HR Officer) has filed a Form 4 on CVS HEALTH Corp
Txns: Granted 2,923 shares @ $67.73, valued at $198k
Paid exercise price by delivering 885 shares @ $67.73, valued at $59.9k
02/02/2018 4 Bisaccia Lisa (Director) has filed a Form 4 on Aramark
Txns: Granted 3,493 shares @ $0
01/09/2018 4 Bisaccia Lisa (Director) has filed a Form 4 on Aramark
Txns: Granted 292 shares @ $42.72, valued at $12.5k
12/22/2017 4 Bisaccia Lisa (EVP and Chief HR Officer) has filed a Form 4 on CVS HEALTH Corp
Txns: Sold 29,445 shares @ $75, valued at $2.2M
12/11/2017 4 Bisaccia Lisa (Director) has filed a Form 4 on Aramark
Txns: Granted 33 shares @ $0
10/10/2017 4 Bisaccia Lisa (Director) has filed a Form 4 on Aramark
Txns: Granted 301 shares @ $41.42, valued at $12.5k
09/07/2017 4 Bisaccia Lisa (Director) has filed a Form 4 on Aramark
Txns: Granted 34 shares @ $0
07/11/2017 4 Bisaccia Lisa (Director) has filed a Form 4 on Aramark
Txns: Granted 310 shares @ $40.24, valued at $12.5k
06/08/2017 4 Bisaccia Lisa (Director) has filed a Form 4 on Aramark
Txns: Granted 34 shares @ $0
04/11/2017 4 Bisaccia Lisa (Director) has filed a Form 4 on Aramark
04/04/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
03/03/2017 4 Bisaccia Lisa (Director) has filed a Form 4 on Aramark
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy